Polygonatum Sibiricum Reduces Visceral Fat in Obese Adults
NCT07759323 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66
Last updated 2026-08-12
Summary
This study is being done to find out if a traditional Chinese herb called Polygonatum sibiricum (Huangjing) can help reduce belly fat and improve metabolic health in adults with visceral obesity.
Visceral obesity means having too much fat stored deep inside the belly, around the organs. This type of fat is linked to a higher risk of diabetes, fatty liver, and heart disease.
The study will include 66 adults with visceral obesity. Participants will be randomly assigned to one of two groups:
One group will receive a Polygonatum sibiricum decoction (15 grams daily) plus standard lifestyle advice on diet and exercise.
The other group will receive the same lifestyle advice only.
The study will last for 12 weeks. Researchers will measure changes in visceral fat area, body weight, waist size, blood sugar, blood lipids, and liver fat. They will also look at gut bacteria and related markers to better understand how Polygonatum sibiricum might work.
Participation involves 4 visits to the study site over the 12-week period. All participants will receive free health assessments and dietitian guidance. The study is not a treatment but a research study to test whether this herb has potential benefits for visceral obesity.
Conditions
- Visceral Obesity
- Metabolic Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Polygonatum sibiricum
Polygonatum sibiricum decoction, 15 g daily, taken orally in 1-2 divided doses after meals, for 12 consecutive weeks. The herbal decoction is prepared by the Pharmaceutical Department of Zhejiang Provincial Tongde Hospital from authenticated Polygonatum sibiricum raw material. Batch number management, dispensing logs, and residual drug recovery are implemented to ensure traceability. All participants in this arm also receive standardized lifestyle intervention (individualized calorie-restricted diet, moderate-intensity aerobic combined with resistance exercise for at least 150 minutes per week, and Traditional Chinese Medicine behavioral guidance). The study is a randomized, open-label, parallel-controlled trial designed to evaluate the effects of Polygonatum sibiricum on visceral fat area and related metabolic parameters.
- BEHAVIORAL
-
Lifestyle Intervention
Standardized lifestyle intervention consisting of three components: (1) individualized calorie-restricted diet prescribed by a dietitian based on each participant's basal metabolic rate and physical activity level, following the principles of total energy control, reduced sugar and fat intake, and regular meals; (2) moderate-intensity aerobic exercise combined with resistance training, with a target of at least 150 minutes per week; and (3) Traditional Chinese Medicine "preventive treatment" behavioral guidance, including sleep management, stress management, and daily living and dietary education. This intervention is provided to all participants in both groups throughout the 12-week study period.
Sponsors & Collaborators
-
Zhejiang Provincial Tongde Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-08-15
- Primary Completion
- 2027-07-30
- Completion
- 2027-07-30
Countries
- China
Study Locations
More Related Trials
-
Observation on Obesity Undergoing XOWI
NCT05122936 ·Status: ENROLLING_BY_INVITATION
-
Shuganhuazhuo Formula for Advanced Hepatocellular Carcinoma With Damp-Heat Syndrome
NCT07691645 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma
NCT03515369 ·Status: UNKNOWN ·Phase: PHASE4
-
Effects of TCM on Beta-cell Function and Insulin Resistance in High Risk Chinese Individuals for T2D (TCM_PDiab_P01)
NCT04441216 ·Status: UNKNOWN ·Phase: NA
-
Effects of Integrated Treatment by Traditional Chinese and Western Medicine in Reducing Cardiovascular Events
NCT01715376 ·Status: COMPLETED
-
The Efficacy of Si-Ni-Tang (a Chinese Herbal Formula) for Severe Sepsis
NCT02777606 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Effect of Integrated Treatment by Traditional Chinese and Western Medicine for Severe Acute Pancreatitis
NCT00506337 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Modified Huanglian Wendan Decoction for Metabolic Syndrome
NCT07702669 ·Status: COMPLETED ·Phase: NA
-
The Clinical Trail Of NAFLD Treated By Traditional Chinese Medicine
NCT01677325 ·Status: COMPLETED ·Phase: PHASE1
-
An Intervention Study of Compound Silymarin in Patients With Non-alcoholic Fatty Liver Disease
NCT05497765 ·Status: COMPLETED ·Phase: NA
-
Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease
NCT01486186 ·Status: UNKNOWN ·Phase: PHASE2
-
Syndrome Differentiation in the Management of Chronic Stable Coronary Artery Disease (SCAD) to Improve Quality
NCT03018769 ·Status: UNKNOWN
-
A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -
NCT02651454 ·Status: COMPLETED ·Phase: PHASE4
-
Traditional Chinese Medicine in Individualized Treatment of Patients With Diabetes Symptoms
NCT01844050 ·Status: COMPLETED ·Phase: NA
-
Idiopathic Pulmonary Fibrosis Cohort of TCM
NCT07162870 ·Status: NOT_YET_RECRUITING
-
Integrated TCM - Western Medicine Strategy for Long - Distance Diabetes Management
NCT07265037 ·Status: RECRUITING ·Phase: NA
-
The Study of Two Different Chinese Traditional Medicine Treatment on Chronic Hepatitis B
NCT03018821 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial of Ruxian Zengsheng No. 1 Decoction
NCT04767620 ·Status: UNKNOWN ·Phase: PHASE2
-
Clinical Study of Chinese Herbal Compound Qidan Xiaoke Granules in Patients After Coronary Revascularization
NCT07616544 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome
NCT06737666 ·Status: RECRUITING ·Phase: PHASE1
-
Traditional Chinese Medicine(TCM) Syndrome Classification of Idiopathic Pulmonary Fibrosis(IPF) and Metabolomics
NCT03711435 ·Status: COMPLETED
-
Study of TLBZT Based Herbal Therapy Plus Chemotherapy for Metastatic Colorectal Cancer
NCT01975454 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Traditional Chinese Medicine on GI Function Recovery and Nutrition Support in SAP
NCT00508729 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of Herbal Formula Corresponding to Syndrome in Treating Post Percutaneous Coronary Intervention (PCI) Patients With Coronary Heart Disease (CHD)
NCT00817024 ·Status: COMPLETED ·Phase: NA
-
Jing Si Herbal Tea for Long-Coronavirus Disease(COVID) Gut-brain Interaction
NCT05668104 ·Status: COMPLETED ·Phase: NA